{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:45:14Z","timestamp":1788219914752,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-244x-12-219","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T18:11:35Z","timestamp":1354731095000},"source":"Crossref","is-referenced-by-count":40,"title":["Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence"],"prefix":"10.1186","volume":"12","author":[{"given":"Suzanne","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macey L","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hodgkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Asherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian CK","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,5]]},"reference":[{"key":"1208_CR1","unstructured":"Attention deficit hyperactivity disorder: pharmacological and psychological interventions in children, young people and adults. http:\/\/www.nice.org.uk\/CG72 ,"},{"issue":"5","key":"1208_CR2","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3109\/15622975.2010.483249","volume":"11","author":"M Rosler","year":"2010","unstructured":"Rosler M, Casas M, Konofal E, Buitelaar J: Attention deficit hyperactivity disorder in adults. World J Biol Psychiatry. 2010, 11 (5): 684-698.","journal-title":"World J Biol Psychiatry"},{"key":"1208_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-244X-10-67","volume":"10","author":"SJ Kooij","year":"2010","unstructured":"Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugue M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken K, Fitzgerald M, et al: European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010, 10: 67-","journal-title":"BMC Psychiatry"},{"issue":"4","key":"1208_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1586\/14737175.5.4.525","volume":"5","author":"P Asherson","year":"2005","unstructured":"Asherson P: Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother. 2005, 5 (4): 525-539.","journal-title":"Expert Rev Neurother"},{"key":"1208_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1192\/bjp.bp.106.034389","volume":"190","author":"J Fayyad","year":"2007","unstructured":"Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, et al: Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry. 2007, 190: 402-409.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"1208_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1192\/bjp.bp.107.048827","volume":"194","author":"V Simon","year":"2009","unstructured":"Simon V, Czobor P, Balint S, Meszaros A, Bitter I: Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009, 194 (3): 204-211.","journal-title":"Br J Psychiatry"},{"key":"1208_CR7","unstructured":"Methylphenidate: atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents Technology Appraisal 98. http:\/\/www.nice.org.uk\/TA98 ,"},{"key":"1208_CR8","volume-title":"International classification of diseases, 10th revision: the classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organisation","year":"1992","unstructured":"World Health Organisation: International classification of diseases, 10th revision: the classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. 1992, Geneva: WHO"},{"key":"1208_CR9","unstructured":"Mental health of children and young people in Great Britain. 2004, http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsStatistics\/DH_4118332 ,"},{"issue":"1","key":"1208_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0006-3223(00)00889-1","volume":"48","author":"SV Faraone","year":"2000","unstructured":"Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE: Attention-deficit\/hyperactivity disorder in adults: an overview. Biol Psychiatry. 2000, 48 (1): 9-20.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"1208_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jama.292.5.619","volume":"292","author":"TE Wilens","year":"2004","unstructured":"Wilens TE, Faraone SV, Biederman J: Attention-deficit\/hyperactivity disorder in adults. JAMA. 2004, 292 (5): 619-623.","journal-title":"JAMA"},{"issue":"3","key":"1208_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1469-7610.2011.02489.x","volume":"53","author":"GH Gudjonsson","year":"2011","unstructured":"Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S: An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry. 2011, 53 (3): 304-312.","journal-title":"J Child Psychol Psychiatry"},{"key":"1208_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-244X-11-32","volume":"11","author":"SJ Young","year":"2011","unstructured":"Young SJ, Adamou M, Bolea B, Gudjonsson G, Muller U, Pitts M, Thome J, Asherson P: The identification and management of ADHD offenders within the criminal justice system: a consensus statement from the UK Adult ADHD Network and criminal justice agencies. BMC Psychiatry. 2011, 11: 32-","journal-title":"BMC Psychiatry"},{"issue":"2","key":"1208_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/S003329170500471X","volume":"36","author":"SV Faraone","year":"2006","unstructured":"Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006, 36 (2): 159-165.","journal-title":"Psychol Med"},{"issue":"5","key":"1208_CR15","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1176\/appi.ajp.157.5.816","volume":"157","author":"J Biederman","year":"2000","unstructured":"Biederman J, Mick E, Faraone SV: Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000, 157 (5): 816-818.","journal-title":"Am J Psychiatry"},{"key":"1208_CR16","unstructured":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Development. http:\/\/www.dsm5.org ,"},{"key":"#cr-split#-1208_CR17.1","unstructured":"Janssen-Cilag Ltd: Concerta XL. Summary of Product Characteristics. Electronic Medicines Compendium. Available from URL: http:\/\/www.medicines.org.uk\/EMC\/medicine\/19549\/SPC\/Concerta;"},{"key":"#cr-split#-1208_CR17.2","unstructured":"[updated 13\/09\/2011] Accessed: 15th November 2011,"},{"key":"#cr-split#-1208_CR18.1","unstructured":"Eli Lilly and Company Limited: Atomoxetine (Strattera) Summary of Product Characteristics. Electronic Medicines Compendium. Available from http:\/\/www.medicines.org.uk\/EMC\/medicine\/14482\/SPC\/Strattera;"},{"key":"#cr-split#-1208_CR18.2","unstructured":"[updated 08\/12\/2011] Accessed: 15th June 2011,"},{"key":"1208_CR19","volume-title":"Canadian ADHD Practice Guidelines","author":"Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA)","year":"2011","unstructured":"Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA): Canadian ADHD Practice Guidelines. 2011, Toronto ON, Third","edition":"Third"},{"issue":"1","key":"1208_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0269881106073219","volume":"21","author":"DJ Nutt","year":"2007","unstructured":"Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E, et al: Evidence-based guidelines for management of attention-deficit\/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2007, 21 (1): 10-41.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"1208_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1192\/bjp.bp.107.045245","volume":"194","author":"S McCarthy","year":"2009","unstructured":"McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, et al: Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009, 194 (3): 273-277.","journal-title":"Br J Psychiatry"},{"issue":"12","key":"1208_CR22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/archpsyc.56.12.1073","volume":"56","author":"The MTA Cooperative Group","year":"1999","unstructured":"The MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999, 56 (12): 1073-1086.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"1208_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1542\/peds.113.4.754","volume":"113","author":"National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up","year":"2004","unstructured":"National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit\/hyperactivity disorder. Pediatrics. 2004, 113 (4): 754-761.","journal-title":"Pediatrics"},{"issue":"8","key":"1208_CR24","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/CHI.0b013e3180686d48","volume":"46","author":"PS Jensen","year":"2007","unstructured":"Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Wells KC, et al: 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry. 2007, 46 (8): 989-1002.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1208_CR25","doi-asserted-by":"publisher","first-page":"c6267","DOI":"10.1136\/bmj.c6267","volume":"341","author":"D McBride","year":"2010","unstructured":"McBride D, Hardoon S, Walters K, Gilmour S, Raine R: Explaining variation in referral from primary to secondary care: cohort study. BMJ. 2010, 341: c6267-","journal-title":"BMJ"},{"issue":"8","key":"1208_CR26","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/pds.1774","volume":"18","author":"K Haynes","year":"2009","unstructured":"Haynes K, Forde KA, Schinnar R, Wong P, Strom BL, Lewis JD: Cancer incidence in The Health Improvement Network. Pharmacoepidemiol Drug Saf. 2009, 18 (8): 730-736.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"1208_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/pds.1784","volume":"18","author":"V Lo Re 3rd","year":"2009","unstructured":"Lo Re V, Haynes K, Forde KA, Localio AR, Schinnar R, Lewis JD: Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Pharmacoepidemiol Drug Saf. 2009, 18 (9): 807-814.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1208_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pds.1335","volume":"16","author":"JD Lewis","year":"2007","unstructured":"Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL: Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007, 16 (4): 393-401.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1208_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2431-12-78","volume":"12","author":"S McCarthy","year":"2012","unstructured":"McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong ICK: The epidemiology of pharmacologically-treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatrics. 2012, 12: 78-","journal-title":"BMC Pediatrics"},{"issue":"4","key":"1208_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al: The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006, 163 (4): 716-723.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1208_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/jpepsy\/jsj122","volume":"32","author":"VA Miller","year":"2007","unstructured":"Miller VA, Drotar D: Decision-making competence and adherence to treatment in adolescents with diabetes. J Pediatr Psychol. 2007, 32 (2): 178-188.","journal-title":"J Pediatr Psychol"},{"key":"1208_CR32","unstructured":"National Service Framework for Children: Young People and Maternity Services. Transition: Getting it Right for Young People. UK: Improving the Transition of Young People with Long-Term Conditions from Children\u2019s to Adult Health Services, http:\/\/www.dh.gov.uk\/assetRoot\/04\/13\/21\/49\/04132149.pdf ,"},{"key":"1208_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1192\/bjp.bp.106.026484","volume":"190","author":"P Asherson","year":"2007","unstructured":"Asherson P, Chen W, Craddock B, Taylor E: Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry. 2007, 190: 4-5.","journal-title":"Br J Psychiatry"},{"key":"1208_CR34","unstructured":"ADHD - Services Over Scotland. Report of the Service Profiling Exercise. http:\/\/www.healthcareimprovementscotland.org\/programmes\/mental_health\/adhd\/adhd_service_profile.aspx ,"},{"issue":"50","key":"1208_CR35","first-page":"1","volume":"13","author":"IC Wong","year":"2009","unstructured":"Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, et al: Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health Technol Assess. 2009, 13 (50): 1-120. iii-iv, ix-xi","journal-title":"Health Technol Assess"},{"issue":"6","key":"1208_CR36","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1017\/S003329170400337X","volume":"35","author":"JJ Kooij","year":"2005","unstructured":"Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP: Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med. 2005, 35 (6): 817-827.","journal-title":"Psychol Med"},{"issue":"1","key":"1208_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1741-7015-10-99","volume":"10","author":"M Shaw","year":"2012","unstructured":"Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE: A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012, 10 (1): 99-","journal-title":"BMC Med"},{"issue":"1","key":"1208_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/pubmed\/fdm085","volume":"30","author":"O Morgan","year":"2008","unstructured":"Morgan O, Griffiths C, Majeed A: Antidepressant prescribing and changes in antidepressant poisoning mortality and suicide in England, 1993\u20132004. J Public Health (Oxf). 2008, 30 (1): 60-68.","journal-title":"J Public Health (Oxf)"},{"issue":"1","key":"1208_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/fampra\/cmp071","volume":"27","author":"E Martin-Merino","year":"2010","unstructured":"Martin-Merino E, Ruigomez A, Wallander MA, Johansson S, Garcia-Rodriguez LA: Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam Pract. 2010, 27 (1): 9-16.","journal-title":"Fam Pract"},{"issue":"11","key":"1208_CR40","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.biopsych.2005.04.001","volume":"57","author":"R Kessler","year":"2005","unstructured":"Kessler R, Adler L, Barkley R, Biederman J, Conners CK, Faraone S, Greenhill L, Jaeger S, Secnik K, Spencer T, et al: Patterns and predictors of ADHD persistence into adulthood: Results from the National Comorbidity Survey Replication. Biol Psychiatry. 2005, 57 (11): 1442-1451.","journal-title":"Biol Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-219\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T06:51:15Z","timestamp":1544597475000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-219","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]},"article-number":"219"}}